R. D. Bock

Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes

G. Tricot, R. Verwilghen, M. Boogaerts, 1984, British journal of haematology.

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

S. Geest, P. Martiat, G. Verhoef, 2009, Blood.

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.

M. Paesmans, T. Calandra, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.

K. Vandewoude, M. Boogaerts, G. Fillet, 2001, The Journal of antimicrobial chemotherapy.

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

M. Paesmans, T. Calandra, C. Viscoli, 1995, Antimicrobial agents and chemotherapy.